Shafique Virani is Chief Business Officer of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 136,748 shares of RXRX, which is worth approximately $1.07 Million. The most recent transaction as insider was on Jun 15, 2023, when has been sold 30,000 shares (Class A Common Stock) at a price of $2.22 per share, resulting in proceeds of $66,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 137K
0% 3M change
2.57% 12M change
Total Value Held $1.07 Million

Shafique Virani Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 15 2023
BUY
Exercise of conversion of derivative security
$66,600 $2.22 p/Share
30,000 Added 14.71%
173,954 Class A Common Stock
Jun 02 2023
SELL
Open market or private sale
$159,534 $8.93 p/Share
17,865 Reduced 11.04%
143,954 Class A Common Stock
Jun 01 2023
SELL
Open market or private sale
$214,500 $8.58 p/Share
25,000 Reduced 13.38%
161,819 Class A Common Stock
May 15 2023
SELL
Payment of exercise price or tax liability
$12,488 $5.6 p/Share
2,230 Reduced 1.19%
185,102 Class A Common Stock
Feb 16 2023
SELL
Open market or private sale
$14,886 $8.42 p/Share
1,768 Reduced 0.93%
187,332 Class A Common Stock
Feb 15 2023
SELL
Open market or private sale
$62,358 $8.33 p/Share
7,486 Reduced 3.79%
189,846 Class A Common Stock
Feb 15 2023
SELL
Payment of exercise price or tax liability
$6,296 $8.44 p/Share
746 Reduced 0.39%
189,100 Class A Common Stock
Feb 15 2023
BUY
Exercise of conversion of derivative security
$16,618 $2.22 p/Share
7,486 Added 3.65%
197,332 Class A Common Stock
Feb 01 2023
SELL
Payment of exercise price or tax liability
$25,598 $8.55 p/Share
2,994 Reduced 1.55%
189,846 Class A Common Stock
Feb 01 2023
BUY
Grant, award, or other acquisition
-
117,090 Added 37.78%
192,840 Class A Common Stock
Jan 17 2023
SELL
Open market or private sale
$91,600 $9.16 p/Share
10,000 Reduced 12.03%
73,160 Class A Common Stock
Jan 17 2023
BUY
Exercise of conversion of derivative security
$11,100 $2.22 p/Share
5,000 Added 5.67%
83,160 Class A Common Stock
Dec 15 2022
SELL
Open market or private sale
$88,500 $8.85 p/Share
10,000 Reduced 11.34%
78,160 Class A Common Stock
Dec 15 2022
BUY
Exercise of conversion of derivative security
$11,100 $2.22 p/Share
5,000 Added 5.37%
88,160 Class A Common Stock
Nov 15 2022
SELL
Payment of exercise price or tax liability
$7,270 $11.86 p/Share
613 Reduced 0.69%
88,160 Class A Common Stock
Nov 15 2022
SELL
Open market or private sale
$123,100 $12.31 p/Share
10,000 Reduced 10.73%
83,160 Class A Common Stock
Nov 15 2022
BUY
Exercise of conversion of derivative security
$11,100 $2.22 p/Share
5,000 Added 5.09%
93,160 Class A Common Stock
Oct 14 2022
SELL
Open market or private sale
$109,200 $10.92 p/Share
10,000 Reduced 10.12%
88,773 Class A Common Stock
Oct 14 2022
BUY
Exercise of conversion of derivative security
$11,100 $2.22 p/Share
5,000 Added 4.82%
98,773 Class A Common Stock
Sep 15 2022
SELL
Open market or private sale
$136,600 $13.66 p/Share
10,000 Reduced 9.64%
93,773 Class A Common Stock
Sep 15 2022
BUY
Exercise of conversion of derivative security
$11,100 $2.22 p/Share
5,000 Added 4.6%
103,773 Class A Common Stock
Aug 16 2022
SELL
Open market or private sale
$378,300 $12.61 p/Share
30,000 Reduced 23.3%
98,773 Class A Common Stock
Aug 16 2022
BUY
Exercise of conversion of derivative security
$55,500 $2.22 p/Share
25,000 Added 16.26%
128,773 Class A Common Stock
Aug 15 2022
SELL
Payment of exercise price or tax liability
$7,944 $12.96 p/Share
613 Reduced 0.59%
103,773 Class A Common Stock
May 16 2022
SELL
Payment of exercise price or tax liability
$4,933 $5.67 p/Share
870 Reduced 0.83%
104,386 Class A Common Stock
SV

Shafique Virani

Chief Business Officer
Salt Lake City, UT

Track Institutional and Insider Activities on RXRX

Follow RECURSION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX